Hakon Hakonarson insider trades: Decode Genetics (DCGN) stock sales
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where Hakon reports to the SEC
Open-market buys and sales
1 trade reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Aug 24, 2005 | DCGN | ↓ Sell | 5,000 | $9.75 | $49K | Direct | Aug 26, 2005 (2d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
About Hakon Hakonarson's insider trades
Hakon Hakonarson is V.P., Clinical Studies at Decode Genetics (DCGN). Since Aug 24, 2005, Hakon has reported no open-market purchases and 1 sale worth $49K on SEC Form 4. There have been no open-market trades in the last 12 months.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every DCGN insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.